These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The fusion protein AML1-ETO in acute myeloid leukemia with translocation t(8;21) induces c-jun protein expression via the proximal AP-1 site of the c-jun promoter in an indirect, JNK-dependent manner. Elsässer A; Franzen M; Kohlmann A; Weisser M; Schnittger S; Schoch C; Reddy VA; Burel S; Zhang DE; Ueffing M; Tenen DG; Hiddemann W; Behre G Oncogene; 2003 Aug; 22(36):5646-57. PubMed ID: 12944913 [TBL] [Abstract][Full Text] [Related]
4. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias. Lo Coco F; Pisegna S; Diverio D Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595 [TBL] [Abstract][Full Text] [Related]
5. AML1/ETO-induced survivin expression inhibits transcriptional regulation of myeloid differentiation. Balkhi MY; Christopeit M; Chen Y; Geletu M; Behre G Exp Hematol; 2008 Nov; 36(11):1449-60. PubMed ID: 18687517 [TBL] [Abstract][Full Text] [Related]
6. Repression of vascular endothelial growth factor expression by the runt-related transcription factor 1 in acute myeloid leukemia. Ter Elst A; Ma B; Scherpen FJ; de Jonge HJ; Douwes J; Wierenga AT; Schuringa JJ; Kamps WA; de Bont ES Cancer Res; 2011 Apr; 71(7):2761-71. PubMed ID: 21447743 [TBL] [Abstract][Full Text] [Related]
7. AML1 and the AML1-ETO fusion protein in the pathogenesis of t(8;21) AML. Licht JD Oncogene; 2001 Sep; 20(40):5660-79. PubMed ID: 11607817 [No Abstract] [Full Text] [Related]
8. ELA2 is regulated by hematopoietic transcription factors, but not repressed by AML1-ETO. Lausen J; Liu S; Fliegauf M; Lübbert M; Werner MH Oncogene; 2006 Mar; 25(9):1349-57. PubMed ID: 16247445 [TBL] [Abstract][Full Text] [Related]
9. Williams-Beuren syndrome critical region-5/non-T-cell activation linker: a novel target gene of AML1/ETO. Fliegauf M; Stock M; Berg T; Lübbert M Oncogene; 2004 Dec; 23(56):9070-81. PubMed ID: 15489901 [TBL] [Abstract][Full Text] [Related]
10. The ETO portion of acute myeloid leukemia t(8;21) fusion transcript encodes a highly evolutionarily conserved, putative transcription factor. Erickson PF; Robinson M; Owens G; Drabkin HA Cancer Res; 1994 Apr; 54(7):1782-6. PubMed ID: 8137293 [TBL] [Abstract][Full Text] [Related]
11. The t(8;21) fusion protein, AML1 ETO, specifically represses the transcription of the p14(ARF) tumor suppressor in acute myeloid leukemia. Linggi B; Müller-Tidow C; van de Locht L; Hu M; Nip J; Serve H; Berdel WE; van der Reijden B; Quelle DE; Rowley JD; Cleveland J; Jansen JH; Pandolfi PP; Hiebert SW Nat Med; 2002 Jul; 8(7):743-50. PubMed ID: 12091906 [TBL] [Abstract][Full Text] [Related]
12. A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis. Yan M; Kanbe E; Peterson LF; Boyapati A; Miao Y; Wang Y; Chen IM; Chen Z; Rowley JD; Willman CL; Zhang DE Nat Med; 2006 Aug; 12(8):945-9. PubMed ID: 16892037 [TBL] [Abstract][Full Text] [Related]
13. Leukemogenic AML1-ETO fusion protein upregulates expression of connexin 43: the role in AML 1-ETO-induced growth arrest in leukemic cells. Li X; Xu YB; Wang Q; Lu Y; Zheng Y; Wang YC; Lübbert M; Zhao KW; Chen GQ J Cell Physiol; 2006 Sep; 208(3):594-601. PubMed ID: 16741927 [TBL] [Abstract][Full Text] [Related]
14. The t(8;21) fusion protein, AML1/ETO, transforms NIH3T3 cells and activates AP-1. Frank RC; Sun X; Berguido FJ; Jakubowiak A; Nimer SD Oncogene; 1999 Mar; 18(9):1701-10. PubMed ID: 10208431 [TBL] [Abstract][Full Text] [Related]
15. Discrimination of target by siRNA: designing of AML1-MTG8 fusion mRNA-specific siRNA sequences. Kasashima K; Sakota E; Kozu T Biochimie; 2004; 86(9-10):713-21. PubMed ID: 15556282 [TBL] [Abstract][Full Text] [Related]
16. CCAAT/enhancer binding protein alpha (C/EBPalpha) and C/EBPalpha myeloid oncoproteins induce bcl-2 via interaction of their basic regions with nuclear factor-kappaB p50. Paz-Priel I; Cai DH; Wang D; Kowalski J; Blackford A; Liu H; Heckman CA; Gombart AF; Koeffler HP; Boxer LM; Friedman AD Mol Cancer Res; 2005 Oct; 3(10):585-96. PubMed ID: 16254192 [TBL] [Abstract][Full Text] [Related]
18. AML-2 is a potential target for transcriptional regulation by the t(8;21) and t(12;21) fusion proteins in acute leukemia. Meyers S; Lenny N; Sun W; Hiebert SW Oncogene; 1996 Jul; 13(2):303-12. PubMed ID: 8710369 [TBL] [Abstract][Full Text] [Related]
19. Block of granulocytic differentiation of 32Dcl3 cells by AML1/ETO(MTG8) but not by highly expressed Bcl-2. Kohzaki H; Ito K; Huang G; Wee HJ; Murakami Y; Ito Y Oncogene; 1999 Jul; 18(28):4055-62. PubMed ID: 10435586 [TBL] [Abstract][Full Text] [Related]
20. The myeloid master regulator transcription factor PU.1 is inactivated by AML1-ETO in t(8;21) myeloid leukemia. Vangala RK; Heiss-Neumann MS; Rangatia JS; Singh SM; Schoch C; Tenen DG; Hiddemann W; Behre G Blood; 2003 Jan; 101(1):270-7. PubMed ID: 12393465 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]